Filter
252
Filtered Results: 252
Text search:
MRSA
Featured
Recommendations
30
New Publications
46
Language
Document type
Guidelines
75
Studies & Reports
73
No document type
65
Manuals
10
Strategic & Response Plan
9
Fact sheets
8
Situation Updates
4
Training Material
2
Infographics
2
Online Courses
2
Brochures
1
Videos
1
Countries / Regions
India
17
South Africa
10
Kenya
7
Africa
7
Western and Central Europe
6
Indonesia
6
Ghana
5
Germany
5
Nepal
4
Nigeria
4
Global
4
Uganda
4
Ethiopia
4
Tanzania
3
Namibia
3
Thailand
2
Syria
2
Peru
2
Zimbabwe
2
Philippines
2
Latin America and the Carribbean
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Argentina
2
Russia
2
Botswana
2
Zambia
2
Myanmar / Burma
2
Pakistan
2
Ukraine
1
El Salvador
1
Sierra Leone
1
Cameroon
1
Iran
1
Laos
1
Senegal
1
Malawi
1
Qatar
1
USA
1
Jordan
1
Saudi Arabia
1
Congo, Democratic Republic of
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Paraguay
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
United Kingdom
1
East and Southern Africa
1
Bolivia
1
Vietnam
1
Sudan
1
Yemen
1
South Sudan
1
Ecuador
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
86
Key Resources
12
Clinical Guidelines
11
Pharmacy & Technologies
6
Capacity Building
5
Women & Child Health
4
Public Health
3
Toolboxes
AMR
138
COVID-19
13
Rapid Response
12
Refugee
7
TB
7
Caregiver
7
Pharmacy
7
Ebola
6
Planetary Health
5
HIV
4
Specific Hazards
2
Mental Health
1
NTDs
1
Conflict
1
Global Health Education
1
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
Using antimicrobials responsibly is an essential component ofefforts to contain antimicrobial resistance (AMR), and to ensurethat patients receive appropriate treatment. The WHO global action plan on AMR emphasizes the importance of training healthcare professionals in antimicrobial prescribing and ...
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of ...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
Antibiotic resistance is no longer a concern for the distant future but is a pressing issue, both globally and in Nepal. As part of global effort to preserve the effectiveness of antibiotics, the Global Antibiotic Resistance Partnership (GARP)-Nepal was established to doc...
El informe anual de la vigilancia de la resistencia a los antibióticos de los países participantes de la Región de las Américas se discute y analiza con el fin de tomar medidas para el perfeccionamiento continuo de la calidad de los datos, y su utilidad en la orientación a los clínicos para el...
Haematologica has published European guidelines for empirical and targeted antibacterial therapy forfebrile neutropenic patients in the era of emerging resistance (ECIL-4). Indeed, collateral damage by broad-spectrum antibiotic therapy includes selection of multidrugresistant pathogens, and incr...
In the kingdom of Bahrain, the national antibiotic committee will set the framework for the national response to AMR, especially bacterial resistance to antibiotics. It will be aligned with the World Health Organization’s (WHO) Global Action Plan on Antimicrobial Resistance, and with standards and...
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.
Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
Infection Prevention and Control Programmes
January 2020
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
This curricula guide builds on several existing products of WHO and partners, aimed at supporting countries in their effort to address the first objective of the GAP-AMR (to improve awareness and understanding of AMR). It is targeted specifically at health educators and policy planners, and applies ...
This manual addresses all the issues. It focus on the cycle of microbes, antibiotics, vaccination, AMR,
infection prevention and control. It will support nurses on better action and also on communication towards
their patients and families.
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
